Herantis Pharma Oyj (HEL: HRTIS)

Herantis Pharma Oyj Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	2023	2022	2021	2020	2019
Period Ending	Aug 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	30	32	28	27	40	52
Market Cap Growth	16.40%	13.79%	4.72%	-34.19%	-21.79%	91.39%
Enterprise Value	26	31	25	26	39	53
Last Close Price	1.49	1.57	1.65	2.28	3.95	7.37
PE Ratio	-	96.78	-2.59	-1.82	-3.19	-5.38
PB Ratio	14.68	6.72	-462.92	-23.37	5.34	27.97
P/FCF Ratio	-5.62	-6.85	-3.12	-2.68	-4.73	-8.69
P/OCF Ratio	-5.62	-6.85	-3.12	-2.68	-4.73	-8.69
EV/EBITDA Ratio	-	-	-3.09	-2.09	-5.40	-7.52
EV/EBIT Ratio	-139.73	203.31	-3.09	-2.09	-4.78	-7.40
EV/FCF Ratio	-4.54	-6.77	-2.76	-2.62	-4.51	-8.88
Debt / Equity Ratio	0.01	0.02	-75.33	-6.43	0.95	3.90
Debt / FCF Ratio	-0.01	-0.02	-0.51	-0.74	-0.84	-1.21
Quick Ratio	2.28	3.38	3.25	2.89	4.67	3.60
Current Ratio	2.30	3.39	3.28	2.91	4.68	3.61
Return on Equity (ROE)	-661.79%	11.99%	-	-396.06%	-193.95%	-908.72%
Return on Assets (ROA)	-2.75%	1.49%	-71.40%	-64.41%	-36.70%	-49.09%
Return on Capital (ROIC)	-5.09%	2.08%	-93.60%	-74.22%	-42.29%	-58.23%
Earnings Yield	-2.19%	0.88%	-33.41%	-47.91%	-22.60%	-15.46%
FCF Yield	-17.79%	-14.60%	-32.05%	-37.28%	-21.14%	-11.51%
Buyback Yield / Dilution	-10.24%	-17.34%	-43.59%	-38.03%	-26.51%	-18.83%
Total Shareholder Return	-10.24%	-17.34%	-43.59%	-38.03%	-26.51%	-18.83%

Source: S&P Capital IQ. Standard template. Financial Sources.